Corrigendum: Clinical efficacy, safety and tolerability of a new subcutaneous immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the treatment of patients with primary immunodeficiencies

Autor:	Roger H. Kobayashi, Sudhir Gupta, Isaac Melamed, J. Fernando Mandujano, Ai Lan Kobayashi, Bruce Ritchie, Bob Geng, Thomas Prescott Atkinson, Syed Rehman, Eva Turpel-Kantor, Jiří Litzman
Jazyk:	angličtina
Rok vydání:	2022
Předmět:	primary immunodeficiencies immunoglobulins antibodies SCIG infections infusion site reactions Immunologic diseases. Allergy RC581-607
Zdroj:	Frontiers in Immunology, Vol 13 (2022)
Druh dokumentu:	article
ISSN:	1664-3224
DOI:	10.3389/fimmu.2022.1110388
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/40b30801152944dcaa8a5c8a21430349 Zobrazit plný text záznamu View record in DOAJ